SCHEMBL9131814

SCHEMBL9131814

COc1ccccc1OC1CCN(CCN2C(=O)c3ccccc3S2(O)O)C1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 4/20 0.47
▸ DRD2 P14416 5/20 0.43
▸ DRD4 P21917 1/20 0.43
▸ DRD5 P21918 1/20 0.43
▸ DRD3 P35462 1/20 0.43
▸ HTR2A P28223 3/20 0.42
▸ HTR7 P34969 3/20 0.42
▸ HTR6 P50406 3/20 0.42
▸ ELANE P08246 1/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ CHRM2 P08172 1/20 0.38
▸ CHRM3 P20309 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9134171 0.94 HTR1A (0.54) HTR1ADRD2DRD4DRD5DRD3
SCHEMBL9131371 0.94 HTR1A (0.51) HTR1ADRD2DRD4DRD5DRD3
SCHEMBL9131013 0.93 DRD2 (0.51) HTR1ADRD2DRD4DRD5DRD3
SCHEMBL9131810 0.89 HTR1A (0.58) HTR1ADRD2DRD4DRD5DRD3
SCHEMBL9131963 0.89 HTR1A (0.45) HTR1ADRD2HTR2AHTR7RAB9A
SCHEMBL9132000 0.86 DRD2 (0.41) HTR1ADRD2DRD4HTR2AHTR7
SCHEMBL9130484 0.86 HTR1A (0.46) HTR1ADRD2HTR2AHTR7HTR6
SCHEMBL9244705 0.83 HTR1A (0.64) HTR1ADRD2DRD4DRD5DRD3
SCHEMBL9134166 0.83 HTR1A (0.66) HTR1ADRD2DRD4DRD5DRD3
SCHEMBL9129056 0.83 HTR1A (0.64) HTR1ADRD2DRD4DRD5DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5453437-A 1,3-disubstituted pyrrolidines BAYER AKTIENGESELLSCHAFT (DE) 1995-09-26 — — US disclosed
US-5274097-A A 1-N-heterocyclic alkylene-3-carbo or heterocyclic ring oxypyrrolidine derivative BAYER AKTIENGESELLSCHAFT (DE) 1993-12-28 — — US disclosed
US-5037841-A For treating nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1991-08-06 — — US disclosed
Send feedback